Active, not recruitingNCT07533656
VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI
Studying Isolated pulmonary artery sling
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Intervention
- No intervention(other)
- Enrollment
- 3600 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07533656 on ClinicalTrials.govOther trials for Isolated pulmonary artery sling
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07517263An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)Novartis Pharmaceuticals
- RECRUITINGPHASE1NCT07513571A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy AdultsAstraZeneca
- RECRUITINGNCT07508007Impact of Implementation Strategies on Lp(a) Testing in Secondary Care SettingsNovartis Pharmaceuticals